Sanofi, Inhibrx deal clears US antitrust waiting period
Sanofi and Inhibrx’s US antitrust waiting period under the Hart-Scott-Rodino Act expired last night, the companies disclosed in a securities filing.Sanofi and Inhibrx’s US antitrust waiting period under the Hart-Scott-Rodino Act...To view the full article, register now.
Already a subscriber? Click here to view full article